Quantcast

Latest University of Massachusetts Medical School Stories

2010-08-11 01:00:00

LONDON, Aug. 11 /PRNewswire/ -- Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company") announces the issuance of United States patent 7,772,203, titled "Methods and Compositions for Controlling Efficacy of RNA Silencing," by the United States Patent and Trademark Office (USPTO). The issued patent generally claims methods of enhancing RNA silencing with a double stranded RNA interference (RNAi) agent. The patent's RNA silencing method claims include coverage for the administering...

2010-07-22 01:49:05

UMass Medical School coordinating a $2.1 million three-year clinical trial Researchers at the University of Massachusetts Medical School (UMMS) believe they may have found a new treatment for retinitis pigmentosa (RP), a severe neurodegenerative disease of the retina that ultimately results in blindness. One of the more common retinal degenerative diseases, RP is caused by the death of photoreceptor cells and affects 1 in 4,000 people in the United States. RP typically manifests in young...

2010-07-07 01:00:00

LONDON, July 7 /PRNewswire/ -- Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company") announces the issuance of United States patent 7,750,144, titled Methods and Compositions for Enhancing Efficacy and Specificity of RNA Silencing, by the United States Patent and Trademark Office (USPTO). The issued patent generally claims methods of producing double stranded (RNAi) agents having decreased off-target silencing activity through certain structural modifications. The ability to...

2010-06-11 01:48:53

In the quest to better understand how the brain chooses between competing behaviors necessary for survival, scientists at the University of Massachusetts Medical School and New York University have isolated two genes in the fruit fly Drosophila that work together to mediate the need to sleep and the need to eat. The study, which appears in the online version of Current Biology, offers insights that may be used to understand sleep-and metabolism-related disorders in humans. "This work...

2010-06-11 01:43:54

A team of biologists has isolated genes that regulate the sleep-feeding conflict. The study, which appears in the latest issue of the journal Current Biology, offers new insights into how the brain chooses between behaviors that are critical for survival. The work was conducted by researchers in New York University's Department of Biology, the Skirball Institute for Biomolecular Medicine at NYU School of Medicine, and the Department of Neurobiology at the University of Massachusetts Medical...

2010-06-09 01:00:00

LONDON, June 9 /PRNewswire/ -- Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company") announces the issuance of United States patent 7,732,593, titled Methods and Compositions For Controlling Efficacy of RNA Silencing, by the United States Patent and Trademark Office (USPTO). The issued patent, which is based on the seminal research of Phillip D. Zamore, Ph.D., Howard Hughes Medical Institute Investigator, the Gretchen Stone Cook Chair of Biomedical Sciences, and Professor of...

2010-04-05 07:05:15

MicroRNA-mediated blood vessel development may have potential Most solid cancers can't grow beyond a limited size without an adequate blood supply and supporting vascular network. Because of this, cancer researchers have sought to understand how a tumor's vascular network develops"”and, more importantly, how to prevent it from developing: If the vascular network never develops, the theory goes, the tumor cannot grow. Researchers at the University of Massachusetts Medical School have...

2010-04-03 09:03:27

Landmark international study of more than 60,000 women highlights need for public education about osteoporosis risk factors and treatment Underscoring what researchers call a serious international public health concern, results from the Global Longitudinal Study of Osteoporosis in Women (GLOW) showed that among women at an elevated level of risk for osteoporosis-associated fractures, there is a failure to perceive the implications of having important risk factors. For example, among...

9c59894415606d94998215f6de0eae3f1
2010-01-25 10:22:04

UMass Medical School neurobiologists use transgenic fruit flies and monarch butterfly transgenes to help define magnetoreception mechanism Building on prior investigation into the biological mechanisms through which monarch butterflies are able to migrate up to 2,000 miles from eastern North America to a particular forest in Mexico each year, neurobiologists at the University of Massachusetts Medical School (UMMS) have linked two related photoreceptor proteins found in butterflies to animal...

2010-01-20 18:19:19

Results of phase 2 clinical trial testing novel antibodies to treat clostridium difficile infection published in the New England Journal of Medicine A combination of two fully human monoclonal antibodies developed by MassBiologics (MBL) of the University of Massachusetts Medical School (UMMS) and Medarex, a wholly owned subsidiary of Bristol-Myers Squibb Co. (NYSE:BMY), when given with standard antibiotics, was shown to reduce recurrence of a debilitating form of diarrhea by 72 percent in...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.